Spectrum Sciences scored a series of slow wins across 2024. The agency kicked off the year with the acquisition of clinical trial enrollment company Continuum Clinical, which came months after the ...

When Spectrum Science owner and CEO Jonathan Wilson is asked to give his big-picture take on the company’s fortunes during 2021, he starts his response by hearkening back to 2013. That’s when Wilson ...